Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
Lung Cancer remains a major cause of death in of both women and men in our society. Lung cancer treatment paradigms have changed enormously as we’ve started to understand the genetic complexity and the multiple driver mutations influencing the disease. Therapeutics directed towards, or to inhibit si...
Đã lưu trong:
| Những tác giả chính: | , |
|---|---|
| Định dạng: | Online |
| Ngôn ngữ: | Tiếng Anh |
| Được phát hành: |
Frontiers Media SA
2021
|
| Những chủ đề: | |
| Truy cập trực tuyến: | 29629 |
| Các nhãn: |
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| _version_ | 1869529637600624640 |
|---|---|
| author | Barbara Melosky Vera Hirsh |
| author_browse | Barbara Melosky Vera Hirsh |
| author_facet | Barbara Melosky Vera Hirsh |
| author_sort | Barbara Melosky |
| collection | Directory of Open Access Books |
| description | Lung Cancer remains a major cause of death in of both women and men in our society. Lung cancer treatment paradigms have changed enormously as we’ve started to understand the genetic complexity and the multiple driver mutations influencing the disease. Therapeutics directed towards, or to inhibit signaling pathways has resulted in increased life spans for our patients. Over the last two decades, we have gone from simple chemotherapy used to treat all, to a personalized medicine approach for the majority. For non-small cell lung cancer patients without driver mutations, the world of immune oncology has arrived. These improved long-term outcomes mean that now our lung cancer patients can live with their cancers, but without progression. The aim of this book is to catalogue the current state of knowledge for the many facets of advanced lung cancer. It describes current treatment approaches for driver mutations, rare mutations, and rare thoracic malignancies such as neuroendocrine tumors. Most importantly, this book addresses the topics of palliative treatment and care which allow our patients to enjoy longer survival with the highest quality of life. We hope you enjoy this e-book. The future is brighter for lung cancer patients and as lung cancer specialists; we finally feel sense optimism about treatment options for our patients. |
| format | Online |
| id | doab-20.500.12854ir-61730 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Frontiers Media SA |
| publisherStr | Frontiers Media SA |
| record_format | ojs |
| spelling | doab-20.500.12854ir-617302024-03-31T13:10:08Z Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine Barbara Melosky Vera Hirsh R5-920 RC254-282 Updates on Diagnoses and Treatments Metastatic NSCLC thema EDItEUR::M Medicine and Nursing Lung Cancer remains a major cause of death in of both women and men in our society. Lung cancer treatment paradigms have changed enormously as we’ve started to understand the genetic complexity and the multiple driver mutations influencing the disease. Therapeutics directed towards, or to inhibit signaling pathways has resulted in increased life spans for our patients. Over the last two decades, we have gone from simple chemotherapy used to treat all, to a personalized medicine approach for the majority. For non-small cell lung cancer patients without driver mutations, the world of immune oncology has arrived. These improved long-term outcomes mean that now our lung cancer patients can live with their cancers, but without progression. The aim of this book is to catalogue the current state of knowledge for the many facets of advanced lung cancer. It describes current treatment approaches for driver mutations, rare mutations, and rare thoracic malignancies such as neuroendocrine tumors. Most importantly, this book addresses the topics of palliative treatment and care which allow our patients to enjoy longer survival with the highest quality of life. We hope you enjoy this e-book. The future is brighter for lung cancer patients and as lung cancer specialists; we finally feel sense optimism about treatment options for our patients. 2021-02-12T07:10:20Z 2021-02-12T07:10:20Z 2018-11-16 17:17:57 2018 book 29629 16648714 9782889453979 https://directory.doabooks.org/handle/20.500.12854/61730 eng Frontiers Research Topics image/jpeg Attribution 4.0 International https://www.frontiersin.org/research-topics/5238/update-on-the-treatment-of-metastatic-non-small-cell-lung-cancer-nsclc-in-new-era-of-personalised-me Frontiers Media SA 10.3389/978-2-88945-397-9 10.3389/978-2-88945-397-9 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889453979 95 open access |
| spellingShingle | R5-920 RC254-282 Updates on Diagnoses and Treatments Metastatic NSCLC thema EDItEUR::M Medicine and Nursing Barbara Melosky Vera Hirsh Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine |
| title | Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine |
| title_full | Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine |
| title_fullStr | Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine |
| title_full_unstemmed | Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine |
| title_short | Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine |
| title_sort | update on the treatment of metastatic non small cell lung cancer nsclc in new era of personalised medicine |
| topic | R5-920 RC254-282 Updates on Diagnoses and Treatments Metastatic NSCLC thema EDItEUR::M Medicine and Nursing |
| topic_facet | R5-920 RC254-282 Updates on Diagnoses and Treatments Metastatic NSCLC thema EDItEUR::M Medicine and Nursing |
| url | 29629 |
| work_keys_str_mv | AT barbaramelosky updateonthetreatmentofmetastaticnonsmallcelllungcancernsclcinneweraofpersonalisedmedicine AT verahirsh updateonthetreatmentofmetastaticnonsmallcelllungcancernsclcinneweraofpersonalisedmedicine |